BIODESIX INC Debt-to-equity in % from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Biodesix Inc quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2025.
  • Biodesix Inc Debt-to-equity for the quarter ending September 30, 2025 was 1.05K %, a 93.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

BIODESIX INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 1.05K +507 +93.8% Sep 30, 2025
Q2 2025 514 -534 -51% Jun 30, 2025
Q1 2025 319 +4.17K Mar 31, 2025
Q4 2024 407 -49.3K -99.2% Dec 31, 2024
Q3 2024 541 -1.38K -71.9% Sep 30, 2024
Q2 2024 1.05K -914 -46.6% Jun 30, 2024
Q1 2024 -3.85K -4.79K -508% Mar 31, 2024
Q4 2023 49.7K +48.9K +6245% Dec 31, 2023
Q3 2023 1.92K +1.17K +154% Sep 30, 2023
Q2 2023 1.96K +1.47K +299% Jun 30, 2023
Q1 2023 943 +568 +151% Mar 31, 2023
Q4 2022 784 +492 +169% Dec 31, 2022
Q3 2022 756 +497 +192% Sep 30, 2022
Q2 2022 492 +723 Jun 30, 2022
Q1 2022 375 Mar 31, 2022
Q4 2021 291 Dec 31, 2021
Q3 2021 259 Sep 30, 2021
Q2 2021 -231 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.